CytoSure™ Genomic DNA Labelling Kits
The labelling of DNA samples used in array comparative genomic hybridisation (aCGH) is a critical step in the experimental process as poor labelling can result in inaccurate data. OGT’s CytoSure Genom...
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative genetics research and biomarker solutions to advance molecular medicine.
The company has three core commercial arms: Genomics, Biomarkers and Licensing. In addition, an Exploratory Research division, headed by Professor Southern, focuses on developing new diagnostic techniques with potential for in-house commercialisation or partnering with diagnostic and pharmaceutical organisations.
With its clear strategic focus, OGT has invested significantly in highly qualified expertise, doubling the workforce over the last 2 years to over 60 people. In anticipation of this rapid expansion, OGT moved to a new, purpose-built facility located in the Begbroke Science Park near Oxford, UK. These strategic decisions have resulted in strong year-on-year revenue growth across all business units. The company plans further expansion fuelled by growth into the clinical research market, a full pipeline of new products and further corporate development opportunities.
OGT’s highly experienced management team are driving this growth through end-user sales and by forging strong relationships with major international corporations including Agilent, Illumina and Roche.
The labelling of DNA samples used in array comparative genomic hybridisation (aCGH) is a critical step in the experimental process as poor labelling can result in inaccurate data. OGT’s CytoSure Genom...
Reliable detection of copy number changes and loss of heterozygosity on a single array for haematological malignancies and solid cancers. The CytoSure Cancer +SNP array delivers: ■ Flexible choice of...
OGT can help you get straight to the variant of interest with whole exome or custom targeted sequencing services. Genefficiency™ targeted sequencing services are designed to be different, leading you...
A high-quality RNA sequencing service designed to deliver cost-effective and rapid access to meaningful transcriptomics results. The Genefficiency™ RNA-Seq Service from OGT provides a new level of as...
Reliable detection of copy number changes for research into a range of genetic disorders. CytoSure Molecular Arrays are designed to accurately identify small intragenic copy number variations (CNVs) ...
An expanding portfolio of NGS panels for research into haematological and solid tumour cancers, as well as library preparation kits for the accurate detection of a wide range of genetic aberrations
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative genetics research and biomarker solutions to advance molecular medicine.
The company has three core commercial arms: Genomics, Biomarkers and Licensing. In addition, an Exploratory Research division, headed by Professor Southern, focuses on developing new diagnostic techniques with potential for in-house commercialisation or partnering with diagnostic and pharmaceutical organisations.
With its clear strategic focus, OGT has invested significantly in highly qualified expertise, doubling the workforce over the last 2 years to over 60 people. In anticipation of this rapid expansion, OGT moved to a new, purpose-built facility located in the Begbroke Science Park near Oxford, UK. These strategic decisions have resulted in strong year-on-year revenue growth across all business units. The company plans further expansion fuelled by growth into the clinical research market, a full pipeline of new products and further corporate development opportunities.
OGT’s highly experienced management team are driving this growth through end-user sales and by forging strong relationships with major international corporations including Agilent, Illumina and Roche.
Begbroke Business and Science Park, Sandy Lane, Yarnton, Oxford, OX5 1PF
Website link